Similarly, the role of IL-6 in cardiovascular disease is being actively investigated in ongoing clinical trials evaluating anti–IL-6 therapies in patients with coronary artery disease and chronic kidney disease [100]. This evidence concerns the gene IL6 and chronic kidney disease.